Status:

COMPLETED

Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study

Lead Sponsor:

AstraZeneca

Conditions:

Obsessive Compulsive Disorder

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

Quetiapine (Seroquel ®), an atypical antipsychotic registered for use in schizophrenia, which has a very low propensity of extrapyramidal and endocrine side-effects, has also been studied as an adjunc...

Eligibility Criteria

Inclusion

  • All patients meet the DSM IV criteria for obsessive-compulsive disorder
  • Y-BOCS score \> 16 if obsessions and compulsions
  • Y-BOCS score \> 10 if only obsessions
  • Y-BOCS score \> 10 if only compulsions
  • Male and female, aged between 18-70 years
  • Female patients of childbearing potential must have a negative pregnancy test and use a reliable method of contraception.
  • Written informed consent

Exclusion

  • Presence of any of the following DSM IV conditions; major depression (with a HDRS\>15, \[17 item\]), bipolar disorder, schizophrenia or any other psychotic condition, tic disorder, substance related disorder during the past 6 months, epilepsy, or any structural CNS disorder or stroke within the last year.
  • Evidence of clinically significant and unstable cardiovascular, gastro-intestinal, pulmonary, renal, hepatic, endocrine or haematological disorders, glaucoma, myocardial infarction within the past year, or micturition abnormalities
  • Patients at risk for suicide
  • Multiple serious drug allergies or known allergy for the trial compounds
  • Use of antipsychotics during 6 months before the screening visit
  • Use of any other psychotropic drug during 6 months before the screening visit
  • Cognitive and behavioural treatment 3 months prior to the screening visit
  • Any known contra-indication against citalopram or quetiapine

Key Trial Info

Start Date :

December 1 2003

Trial Type :

INTERVENTIONAL

End Date :

August 1 2006

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT00318539

Start Date

December 1 2003

End Date

August 1 2006

Last Update

January 21 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Research Site

Utrecht, Netherlands